COVID-19 booster associated with significantly improved protection against infection in at-risk adults aged 60 and older; spotlighting health risks of climate change for farmworkers; uninsured rate remains stable despite pandemic.
According to the findings of a study published yesterday by the Health Ministry of Israel, adults aged 60 and older who were administered a third vaccine dose exhibited significantly improved protection against infection and severe illness compared with those who received 2 shots. As reported by Reuters, the participating age group were noted to be particularly vulnerable to COVID-19, and these individuals were among the first to be inoculated when vaccination began in December 2020. Although full details of the study were not released, the findings indicate that the booster shot provided 5 to 6 times greater protection after 10 days against serious illness and hospitalization.
As health risks of climate change continue to affect Americans nationwide, an article by Kaiser Health News spotlighted farmworkers on the frontlines of extreme weather events in California’s Riverside County. Notably, California registered its hottest June and July, with 3 of the desert communities in the county, including Coachella, Indio, and Palm Springs, all reporting record highs in temperatures that surpassed 120 °F. With no federal assistance amid the pandemic, many farmers worked throughout extreme weather conditions, in which Latinos, who represent a majority of California’s farmworkers, were cited to be more at-risk of having conditions that can be exacerbated by extreme heat, such as high blood pressure and kidney disease.
Findings published today of an Urban Institute analysis indicate that percentages of US adults without health insurance remained constant, at approximately 11%, from March 2019 to April 2021, despite the impact of the pandemic. Funded by the Robert Wood Johnson Foundation, the study also found significant shifts in sources of coverage for many people, with Americans receiving employer-sponsored coverage declining from 65% to 62.3%, a decrease of 5.5 million adults, and those reporting public coverage increasing from 13.6% to 17.5%, an increase of 7.9 million adults.
Exclusive Telemedicine Use Linked to Less Favorable Glycemic Outcomes for T2D Endocrinology Care
December 6th 2023Adults with type 2 diabetes (T2D) undergoing endocrinology care are more likely to experience less favorable hemoglobin A1c improvements if they only use telemedicine compared with patients using in-person care or a mix of both.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Dr Kathryn Lindley Explains the Importance of Cardio-Obstetrics in Fellowship Programs
December 5th 2023Kathryn Lindley, MD, FACC, Vanderbilt University Medical Center, talks about why it’s important to incorporate cardio-obstetrics training into cardiovascular disease fellowship programs.
Read More
New Data Update Myasthenia Gravis Outcomes for Patients in Australia
December 3rd 2023Patients living with myasthenia gravis in Australia were surveyed their demographic information, clinical features of the autoimmune disease, adverse effects from treatment, and quality of life. Outcomes were compared against 2011 data from Australia and 2019 data from the United States.
Read More